Day: December 8, 2021

In-line with XVIVO’s Dedication to the US Market, Fredrik Dalborg is Appointed Managing Director North America

Staff December 8, 2021

GOTHENBURG, SWEDEN / ACCESSWIRE / December 08, 2021 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)To successfully execute on XVIVO's strategy,...

Promore Pharma Granted US Patent Regarding Treatment Of Chronic Wounds

Staff December 8, 2021

STOCKHOLM, SWEDEN / ACCESSWIRE / December 08, 2021 / Promore Pharma (STO:PROMO) (FRA:8T0)STOCKHOLM, 8 December 2021 - Promore Pharma AB,...

Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus Infection

Staff December 8, 2021

SAN DIEGO, CA / ACCESSWIRE / December 7, 2021 / Ainos, Inc. ("we", "our", or the "company"), (OTC PINK:AIMD), a...

Day: December 8, 2021

In-line with XVIVO’s Dedication to the US Market, Fredrik Dalborg is Appointed Managing Director North America

Promore Pharma Granted US Patent Regarding Treatment Of Chronic Wounds

Ainos Announces Strategic Relationship with InnoPharmax to Jointly Develop Combined Oral Therapy for Coronavirus Infection

Defence to Participate in 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting in Toronto on June 11, 2024

Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity

Haoxi Health Technology Limited Facilitates International Humanitarian Aid Efforts Amid Global Challenges

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

Akero Therapeutics Presents Poster and Late-breaking Oral Presentation on EFX at the EASL Congress 2024

You may have missed